{
    "Trade/Device Name(s)": [
        "AmpliVue\u00ae GBS Assay"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K133503",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112125"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "NJR"
    ],
    "Summary Letter Date": "December 20, 2013",
    "Summary Letter Received Date": "November 14, 2013",
    "Submission Date": "November 13, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.3740"
    ],
    "Regulation Name(s)": [
        "Streptococcus spp. serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Thiolase (atoB) gene of Streptococcus agalactiae (Group B Streptococcus)"
    ],
    "Specimen Type(s)": [
        "Vaginal swab",
        "Rectal swab",
        "Lim enrichment broth culture"
    ],
    "Specimen Container(s)": [
        "Swab",
        "Enrichment broth tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Helicase-dependent amplification (HDA)",
        "Manual detection with self-contained cassette"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Isothermal amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Detection system",
        "Cassette",
        "Cartridge",
        "Buffer",
        "Tube"
    ],
    "Document Summary": "FDA 510(k) summary for AmpliVue\u00ae GBS Assay, a qualitative in vitro diagnostic test using helicase-dependent amplification for rapid detection of Group B Streptococcus from vaginal/rectal swabs in antepartum women",
    "Indications for Use Summary": "Qualitative in vitro diagnostic assay for rapid detection of Group B Streptococcus in vaginal/rectal swabs from antepartum women after LIM broth incubation, aiding colonization status determination; not for susceptibility testing or point-of-care use",
    "fda_folder": "Microbiology"
}